PHR2229
Levofloxacin Related Compound B
Pharmaceutical Secondary Standard; Certified Reference Material
Manufacturer: Supelco
CAS Number: 100986-89-8
Synonym(S): (S)-(−)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | PHR2229-100-MG | In Stock | ₹ 52,111.55 |
PHR2229 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 52,111.55
GST (18%): ₹ 9,380.079
Total Price: ₹ 61,491.629
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to Ph. Eur. Y0002084traceable to USP 1362125
API family
levofloxacin
optical activity
[α]20/D -64°, c = 1% in DMSO
CofA
current certificate can be downloaded
packaging
pkg of 100 mg
mp
>300 °C (lit.)
application(s)
pharmaceutical small molecule
storage temp.
2-30°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Levofloxacin Related Compound B, Certified Reference Material, MilliporeSigma™ Supelco™ | -- | ₹ 58,028.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Levofloxacin Related Compound B United States Pharmacopeia (USP) Reference Standard | 100986-89-8 | MFCD04039905 | 35MG | -- | ₹ 1,48,078.20 | ||
Sigma Aldrich Fine Chemicals Biosciences (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid 97% | 100986-89-8 | MFCD04039905 | 5G | -- | ₹ 6,853.00 | ||
eMolecules (S)-9,10-Difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid | 100986-89-8 | MFCD04039905 | 25g | -- | ₹ 10,378.29 | ||
Levofloxacin impurity F | -- | ₹ 14,072.50 | ||
(S)-(−)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | -- | ₹ 5,423.33 | ||
Levofloxacin Q-acid | -- | ₹ 623.00 - ₹ 25,187.00 | ||
100986-89-8 | Levofloxacin carboxylic acid | -- | ₹ 623.00 - ₹ 6,942.00 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
- Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
- Footnote: To see an example of a Certificate of Analysis for this material enter LRAC3409 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable